• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代骨组织形态计量学中的问题。

Issues in modern bone histomorphometry.

机构信息

Osteoporosis Research Center, Creighton University, 601 N 30th St Omaha, NE 68131, USA.

出版信息

Bone. 2011 Nov;49(5):955-64. doi: 10.1016/j.bone.2011.07.017. Epub 2011 Jul 23.

DOI:10.1016/j.bone.2011.07.017
PMID:21810491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3274956/
Abstract

This review reports on proceedings of a bone histomorphometry session conducted at the Fortieth International IBMS Sun Valley Skeletal Tissue Biology Workshop held on August 1, 2010. The session was prompted by recent technical problems encountered in conducting histomorphometry on bone biopsies from humans and animals treated with anti-remodeling agents such as bisphosphonates and RANKL antibodies. These agents reduce remodeling substantially, and thus cause problems in calculating bone remodeling dynamics using in vivo fluorochrome labeling. The tissue specimens often contain few or no fluorochrome labels, and thus create statistical and other problems in analyzing variables such as mineral apposition rates, mineralizing surface and bone formation rates. The conference attendees discussed these problems and their resolutions, and the proceedings reported here summarize their discussions and recommendations.

摘要

这篇综述报告是在 2010 年 8 月 1 日举行的第四十届国际 IBMS 太阳谷骨骼组织生物学研讨会上的骨组织形态计量学会议上的报告。此次会议是由在使用抗重塑剂(如双磷酸盐和 RANKL 抗体)治疗的人类和动物的骨活检中进行骨组织形态计量学所遇到的一些最新技术问题而引发的。这些试剂会大大减少重塑,因此在用体内荧光标记物计算骨重塑动力学时会产生问题。组织标本通常很少或没有荧光标记物,因此在分析矿物质沉积率、矿化表面和骨形成率等变量时会产生统计和其他问题。会议与会者讨论了这些问题及其解决方案,这里报告的会议记录总结了他们的讨论和建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/3274956/70b621f016e2/nihms350906f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/3274956/70b621f016e2/nihms350906f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec61/3274956/70b621f016e2/nihms350906f1.jpg

相似文献

1
Issues in modern bone histomorphometry.现代骨组织形态计量学中的问题。
Bone. 2011 Nov;49(5):955-64. doi: 10.1016/j.bone.2011.07.017. Epub 2011 Jul 23.
2
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.特立帕肽或唑来膦酸治疗患者的骨骼组织形态计量学(SHOTZ)研究:一项随机对照试验。
J Clin Endocrinol Metab. 2012 Aug;97(8):2799-808. doi: 10.1210/jc.2012-1262. Epub 2012 Jun 14.
3
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].[唑来膦酸每年5毫克用于绝经后骨质疏松症的安全性和耐受性证据:HORIZON项目]
Reumatismo. 2009 Jan-Mar;61(1):54-64. doi: 10.4081/reumatismo.2009.54.
4
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.每年一次静脉注射唑来膦酸对骨重塑和骨结构的影响。
J Bone Miner Res. 2008 Jan;23(1):6-16. doi: 10.1359/jbmr.070906.
5
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.在去卵巢食蟹猴中,使用完全人源化 RANKL 抗体地舒单抗治疗可减少骨重建和孔隙率,从而改善骨强度。
Bone. 2011 Aug;49(2):151-61. doi: 10.1016/j.bone.2011.03.769. Epub 2011 Mar 30.
6
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.双膦酸盐或 RANK 配体抑制剂治疗前列腺癌伴骨转移的男性患者:一项网状荟萃分析。
Cochrane Database Syst Rev. 2020 Dec 3;12(12):CD013020. doi: 10.1002/14651858.CD013020.pub2.
7
Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial.地诺单抗治疗伴有骨转移的前列腺癌及静脉注射双膦酸盐治疗后尿N-端肽水平升高:一项随机II期试验的结果
J Urol. 2009 Aug;182(2):509-15; discussion 515-6. doi: 10.1016/j.juro.2009.04.023. Epub 2009 Jun 13.
8
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全症的双膦酸盐治疗
Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4.
9
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全的双膦酸盐治疗
Cochrane Database Syst Rev. 2014 Jul 23(7):CD005088. doi: 10.1002/14651858.CD005088.pub3.
10
Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.双膦酸盐可独立于大鼠股骨和胫骨的骨吸收来抑制骨膜成骨细胞活性。
Bone. 2006 Nov;39(5):1053-1058. doi: 10.1016/j.bone.2006.05.006. Epub 2006 Jun 27.

引用本文的文献

1
Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis.将Msx2作为破骨细胞融合命运的制动器及骨质疏松症临床前模型中的一种合成代谢疗法。
Nat Commun. 2025 Aug 6;16(1):7228. doi: 10.1038/s41467-025-61938-0.
2
Mild antiresorptive activity of an anti-vascular endothelial growth factor A antibody and sunitinib in a rat model of bone resorption.抗血管内皮生长因子A抗体和舒尼替尼在大鼠骨吸收模型中的轻度抗骨吸收活性。
Bone Rep. 2025 Mar 17;25:101837. doi: 10.1016/j.bonr.2025.101837. eCollection 2025 Jun.
3
Histomorphometric Assessment of Non-Decalcified Plastic-Embedded Specimens for Evaluation of Bone Regeneration Using Bone Substitute Materials-A Systematic Review.使用骨替代材料评估骨再生的非脱钙塑料包埋标本的组织形态计量学评估——一项系统综述
Materials (Basel). 2024 Dec 30;18(1):119. doi: 10.3390/ma18010119.
4
Does vanillic acid affect fracture healing? An experimental study in a rat model of femur fracture.香草酸会影响骨折愈合吗?股骨骨折大鼠模型的实验研究。
J Appl Biomed. 2024 Jun;22(2):67-73. doi: 10.32725/jab.2024.010. Epub 2024 Jun 17.
5
Retrospective Characterization of Bone Histomorphometric Findings in Clinical Patient Specimens.临床患者标本骨组织形态计量学结果的回顾性特征分析
J Bone Metab. 2024 May;31(2):132-139. doi: 10.11005/jbm.2024.31.2.132. Epub 2024 May 31.
6
Long-Term Structural Changes in the Osteochondral Unit in Patients with Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatment.骨关节炎患者接受富含血小板血浆或基质血管成分治疗的截骨矫形术后骨软骨单元的长期结构变化
Biomedicines. 2024 May 9;12(5):1044. doi: 10.3390/biomedicines12051044.
7
Hormonal and non-hormonal oral contraceptives given long-term to pubertal rats differently affect bone mass, quality and metabolism.长期给予青春期大鼠的激素和非激素口服避孕药会对骨量、质量和代谢产生不同的影响。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1233613. doi: 10.3389/fendo.2023.1233613. eCollection 2023.
8
Ultrasound-Guided Block of the Sciatic and the Femoral Nerves in Rabbits-A Descriptive Anatomical Study.兔坐骨神经和股神经的超声引导阻滞——一项描述性解剖学研究
Animals (Basel). 2023 Jul 24;13(14):2393. doi: 10.3390/ani13142393.
9
The effect of quercetin on bone healing in an experimental rat model.槲皮素对实验性大鼠模型骨愈合的影响。
Jt Dis Relat Surg. 2023 Apr 26;34(2):365-373. doi: 10.52312/jdrs.2023.870.
10
Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.在骨折风险增加的患者中,将运动或体力活动添加到骨质疏松症药物治疗中是否能提高骨密度并降低骨折风险?系统评价和荟萃分析。
Osteoporos Int. 2023 Nov;34(11):1867-1880. doi: 10.1007/s00198-023-06829-0. Epub 2023 Jul 11.

本文引用的文献

1
Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.犬基本多细胞单位吸收参数的形态学评估显示双膦酸盐对骨骼作用的其他机制。
Calcif Tissue Int. 2010 Jan;86(1):67-71. doi: 10.1007/s00223-009-9315-x. Epub 2009 Dec 2.
2
Giant osteoclast formation and long-term oral bisphosphonate therapy.巨大破骨细胞形成与长期口服双膦酸盐治疗。
N Engl J Med. 2009 Jan 1;360(1):53-62. doi: 10.1056/NEJMoa0802633.
3
How can bone turnover modify bone strength independent of bone mass?骨转换如何在不依赖骨量的情况下改变骨强度?
Bone. 2008 Jun;42(6):1014-20. doi: 10.1016/j.bone.2008.02.001. Epub 2008 Feb 20.
4
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.每年一次静脉注射唑来膦酸对骨重塑和骨结构的影响。
J Bone Miner Res. 2008 Jan;23(1):6-16. doi: 10.1359/jbmr.070906.
5
Transmenopausal changes in the trabecular bone structure.绝经后小梁骨结构的变化。
Bone. 2007 Jul;41(1):111-6. doi: 10.1016/j.bone.2007.03.019. Epub 2007 Apr 10.
6
Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.骨重塑在绝经后的几年中大幅增加,并且在老年骨质疏松症患者中持续增加。
J Bone Miner Res. 2004 Oct;19(10):1628-33. doi: 10.1359/JBMR.040710. Epub 2004 Jul 21.
7
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.绝经后骨质疏松症女性每日及间歇性口服伊班膦酸钠的组织形态计量学评估:BONE研究结果
Osteoporos Int. 2004 Mar;15(3):231-7. doi: 10.1007/s00198-003-1530-0. Epub 2004 Jan 16.
8
Measurement of bone formation in a 57 year old man by means of tetracyclines.通过四环素对一名57岁男性的骨形成进行测量。
Henry Ford Hosp Med Bull. 1960 Jun;8:239-54.
9
Mechanical consequences of bone loss in cancellous bone.松质骨骨量丢失的力学后果。
J Bone Miner Res. 2001 Mar;16(3):457-65. doi: 10.1359/jbmr.2001.16.3.457.
10
Apoptosis and osteoporosis.细胞凋亡与骨质疏松症
Am J Med. 2000 Feb;108(2):153-64. doi: 10.1016/s0002-9343(99)00420-9.